The reduction in viral titers was highly significant for all three tested RNA doses.
← all excerpts
A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections.
1
—
—
The reduction in viral titers was highly significant for all three tested RNA doses.